Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1996 Mar;103(3):436–441. doi: 10.1111/j.1365-2249.1996.tb08299.x

Enhancing effect of oxygen radical scavengers on murine macrophage anticryptococcal activity through production of nitric oxide

M TOHYAMA 1, K KAWAKAMI 1, M FUTENMA 1, A SAITO 1
PMCID: PMC2200379  PMID: 8608643

Abstract

We examined the roles of reactive nitrogen intermediates (RNI) and reactive oxygen intermediates (ROI) in interferon-gamma (IFN-γ)-induced cryptococcostatic activity of murine peritoneal macrophages using NG-monomethyl-L-arginine (L-NMMA), a competitive inhibitor of RNI synthesis, and superoxide dismutase (SOD) and catalase, oxygen radical scavengers. IFN-γ-activated macrophages produced nitric oxide (NO) in a dose-dependent manner, as measured by increased nitrite concentration in the culture supernatant. IFN-γ also enhanced the suppressive effect on cryptococcal growth in a similar dose-dependent manner. The induction of killing activity and NO production by an optimal dose of IFN-γ (100 U/ml) was virtually suppressed by 500 μM L-NMMA. These results confirmed the importance of the RNI-mediated effector mechanism in anticryptococcal activity of macrophages. SOD and catalase significantly enhanced the cryptococcostatic activity of macrophages induced by a suboptimal dose of IFN-γ (20 U/ml). The augmenting effect of these reagents was mediated by NO, since they potentiated the production of NO by macrophages and their effects were totally blocked by L-NMMA. Our results indicate that the IFN-γ-induced anticryptococcal activity of macrophages is dependent mostly on RNI, and suggest that the ROI system down-regulates the effector mechanism for cryptococcostasis by suppressing the RNI system.

Keywords: Cryptococcus neoformans, macrophages, interferon-gamma nitric oxide, superoxide, oxygen radical scavengers

Full Text

The Full Text of this article is available as a PDF (565.2 KB).

References

  • 1.Walker L, Lowries DB. Killing of Mycobacterium microti by immunologically activated macrophages. Nature. 1981;293:69–71. doi: 10.1038/293069a0. [DOI] [PubMed] [Google Scholar]
  • 2.Chan J, Xing Y, Magliozzo RS, Bloom BR. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med. 1992;175:1111–22. doi: 10.1084/jem.175.4.1111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Murray HW, Rubin SM, Carriero SM, Harris AM, Jaffee EA. Human mononuclear phagocyte antiprotozoal mechanisms: oxygen-dependent vs. oxygen-independent activity against intracellular Toxoplasma gondii. J Immunol. 1985;134:1982–8. [PubMed] [Google Scholar]
  • 4.Rothermel CD, Rubin BY, Jaffe EA, Murray HW. Oxygen-independent inhibition of intracellular Chlamydia psittaci growth by human monocytes and interferon-γ-activated macrophages. J Immunol. 1986;137:689–92. [PubMed] [Google Scholar]
  • 5.Hibbs JB, Jr, Taintor RR, Vavrin Z. Macrophage cytotoxicity: role for L-arginine deaminase and amino nitrogen oxidation to nitrite. Science. 1987;197:473–6. doi: 10.1126/science.2432665. [DOI] [PubMed] [Google Scholar]
  • 6.Denis M. Interferon-gamma-treated macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. Cell Immunol. 1991;132:150–7. doi: 10.1016/0008-8749(91)90014-3. [DOI] [PubMed] [Google Scholar]
  • 7.Adams LB, Franzblau SG, Vavrin Z, Hibbs JB, Jr, Krahenbuhl JL. L-arginine-dependent macrophage effector functions inhibit metabolic activity of Mycobacterium leprae. J immunol. 1991;147:1642–6. [PubMed] [Google Scholar]
  • 8.Granger DL, Hibbs JB, Jr, Perfect JR, Durack DT. Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages. J Clin Invest. 1990;85:264–7. doi: 10.1172/JCI114422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Liew FY, Millott S, Parkinson C, Palmer RM, Moncada S. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-argnine. J Immunol. 1990;144:4794–7. [PubMed] [Google Scholar]
  • 10.James SL, Glaven J. Macrophage cytotoxity against schistosomula of Schistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates. J Immunol. 1989;143:4208–12. [PubMed] [Google Scholar]
  • 11.Langermans JAM, Van der Hulst MEB, Nibbering PH, Hiemstra PS, Fransen L, Van Furth R. IFN-γ-induced L-arginine-dependent toxoplasmatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-α. J Immunol. 1992;148:568–74. [PubMed] [Google Scholar]
  • 12.Gazzinelli RT, Oswald IP, Hieny S, James SL, Sher A. The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta. Eur J Immunol. 1992;22:2501–6. doi: 10.1002/eji.1830221006. [DOI] [PubMed] [Google Scholar]
  • 13.Stuehr DJ, Marletta MA. Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines or interferon-γ. J immunol. 1987;139:518–25. [PubMed] [Google Scholar]
  • 14.Desai SD, Birdi TJ, Antia NH. Correlation between macrophage activation and bactericidal function and Mycobacterium leprae antigen presentation in macrophages of leprosy patients and normal individuals. Infect Immun. 1989;57:1311–7. doi: 10.1128/iai.57.4.1311-1317.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Kawakami K, Kohno S, Kadota J, et al. T cell-dependent activation of macrophages and enhancement of their phagocytic activity in the lungs of mice inoculated with heat-killed Cryptococcus neoformans: involvement of IFN-γ and its protective effect against cryptococcal infection. Microbiol Immunol. 1995;39:135–43. doi: 10.1111/j.1348-0421.1995.tb02180.x. [DOI] [PubMed] [Google Scholar]
  • 16.Nacy CA, Fortier AH, Meltzer MS, Buchmeier NA, Schreiber RD. Macrophage activation to kill Leishmania major activation of macrophages for intracellular destruction of amastiogotes can be induced by both recombinant interferon-γ and non-interferon lymphokines. J Immunol. 1985;135:3505–11. [PubMed] [Google Scholar]
  • 17.Esparza I, Mannel D, Ruppel A, Falk W, Krammer PH. Interferon γ and lymphotoxin or tumor necrosis factor act synergistically to induce macrophage killing of tumor cells and schistosomula of Schistosoma mansoni. J Exp Med. 1987;166:589–94. doi: 10.1084/jem.166.2.589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Reed SG, Nathan CF, Pihl DL, Rodricks P, Shanebeck K, Conlon PJ, Grabstein KH. Recombinant granulocyte/macrophage colonystimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide. J Exp Med. 1987;166:1734–46. doi: 10.1084/jem.166.6.1734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Stevens DA. Fungal infections in AIDS patients. Br J Clin Practice. 1990;44(Suppl. 1):11–22. [PubMed] [Google Scholar]
  • 20.Murphy JW. Cryptococcosis. In: Cox RA, editor. Immunology of fungal diseases. Boca Raton: CRC Press; 1989. pp. 93–138. [Google Scholar]
  • 21.Brummer E, Stevens D. Anticryptococcal activity of macrophages: role of mouse strain, C5, contact, and L-arginine. Cell Immunol. 1994;157:1–10. doi: 10.1006/cimm.1994.1200. [DOI] [PubMed] [Google Scholar]
  • 22.Stuehr DJ, Nathan CF. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp med. 1989;169:1543–55. doi: 10.1084/jem.169.5.1543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Alspaugh JA, Granger DL. Inhibition of Cryptococcus neoformans replication by nitrogen oxides supports the role of these molecules as effectors of macrophages-mediated cytostasis. Infect Immun. 1991;59:2291–6. doi: 10.1128/iai.59.7.2291-2296.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Jacobson ES, Tinnell SB. Antioxidant function of fungal melanin. J Bacteriol. 1993;175:7102–4. doi: 10.1128/jb.175.21.7102-7104.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Densen P, Clark RA, Nauseef WM. Granulocytic phagocytes. In: Mansel GL, Bennet JE, Dolin R, editors. Principle and practice of infectious diseases. New York: Churchill Livingstone Inc; 1995. pp. 78–101. [Google Scholar]
  • 26.Klein J. Defence reactions mediated by phagocytes. In: Klein J, editor. Immunology. Oxford: Blackwell Scientific Publications Inc; 1990. pp. 311–34. [Google Scholar]
  • 27.Flesch IEA, Kaufmann SHE. Attempts to characterize the mechanisms involved in mycobacterial growth inhibition by gamma-inter-feron-activated bone marrow macrophages. Infect Immun. 1988;56:1464–9. doi: 10.1128/iai.56.6.1464-1469.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Murray HW, Cartelli DM. Killing intracellular Leishmania donovani by human mononuclear phagocytes: evidence for oxygen-dependent and -independent leishmaniacidal activity. J Clin Invest. 1983;72:32–44. doi: 10.1172/JCI110972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Scott P, James S, Sher A. The respiratory burst is not required for killing of intracellular and extracellular parasites by a lymphokine-activated macrophage cell line. Eur J Immunol. 1985;15:553–8. doi: 10.1002/eji.1830150605. [DOI] [PubMed] [Google Scholar]
  • 30.Kwon-Chung KJ, Polacheck I, Popkin TJ. Melanin-lacking mutants of Cryptococcus neoformans and their virulence for mice. J Bacteriol. 1982;150:1414–21. doi: 10.1128/jb.150.3.1414-1421.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.McCall TB, Boughton-Smith NK, Palmer RMJ, Whittle BJR, Moncada S. Synthesis of nitric oxide from L-arginine by neutrophils: release and interaction with superoxide anion. Biochem J. 1989;261:293–6. doi: 10.1042/bj2610293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Albina JE, Mills CD, Henry WL, Jr, Caldwell MD. Regulation of macrophage physiology by L-arginine: role of the oxidative L-arginine deiminase pathway. J Immunol. 1989;143:3641–6. [PubMed] [Google Scholar]
  • 33.Carreras MC, Pargament GA, Catz SD, Poderoso JJ, Boveris A. Kinetics of nitric oxide and hydrogen peroxide production and formation of peroxynitrite during the respiratory burst of human neutrophils. FEBS Lett. 1994;341:65–68. doi: 10.1016/0014-5793(94)80241-6. [DOI] [PubMed] [Google Scholar]
  • 34.Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature. 1986;320:454–6. doi: 10.1038/320454a0. [DOI] [PubMed] [Google Scholar]
  • 35.Zhu L, Gunn C, Beckman JS. Bactericidal activity of peroxynitrite. Arch Biochem Biophys. 1992;298:425–7. doi: 10.1016/0003-9861(92)90434-x. [DOI] [PubMed] [Google Scholar]
  • 36.Denicola A, Rubbo H, Rodriguez D, Radi R. Peroxynitrite-mediated cytotoxicity to Trypanosoma cruzi. Arch Bikochem Biophys. 1993;304:279–86. doi: 10.1006/abbi.1993.1350. [DOI] [PubMed] [Google Scholar]
  • 37.Clancy RM, Leszczynska-Piziak J, Abramson SB. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J Clin Invest. 1992;90:1116–21. doi: 10.1172/JCI115929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 1992;6:3051–64. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES